MRP2 as a Targetable Oxaliplatin Resistance Factor in Gastrointestinal Cancer
Despite the severe adverse effects, toxicity and limited efficacy due to the development of multidrug resistance (MDR), chemotherapy is still the treatment of choice for most of the cancer patients. One of the formidable MDR mechanisms is the up-regulation of various efflux pumps, known as the ATP b...
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Others |
| Published: |
Auckland University of Technology,
2018-11-20T02:45:45Z.
|
| Subjects: | |
| Online Access: | Get fulltext |